Can Combination Therapy with Endothelin Receptor Antagonist and PDE5 Inhibitors Prevent Echocardiographic Findings Suspicious for Pulmonary Arterial Hypertension? Description of a Real-Life Case Series

Objective: To retrospectively evaluate the incidence rate (IR) of elevated echocardiographic estimated systolic pulmonary artery pressure (sPAP), suspected for pulmonary hypertension (PH), in systemic sclerosis (SSc) patients after the introduction of a combination therapy with bosentan and sildenaf...

Full description

Bibliographic Details

Published in:	Diagnostics
Main Authors:	Arianna Damiani, Gemma Lepri, Francesco Bonomi, Elisa Fiorentini, Silvia Peretti, Jelena Blagojevic, Silvia Bellando Randone, Serena Guiducci
Format:	Article
Language:	English
Published:	MDPI AG 2024-07-01
Subjects:	systemic sclerosis pulmonary hypertension phosphodiesterase-5 inhibitors endothelin receptor antagonist
Online Access:	https://www.mdpi.com/2075-4418/14/14/1526